Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Insulet
MedTech
Insulet boosts guidance in Q1 as it grapples with recall saga
Insulet is upping its guidance after a strong first quarter, though ongoing recalls continue to cast a shadow for investors.
Ben Adams
May 7, 2026 8:55am
Insulet recalls certain Omnipod 5 pumps over insulin leaks
Mar 13, 2026 1:12pm
Insulet, Abbott, Dexcom set sights on Type 2 diabetes at ATTD
Mar 12, 2026 1:07pm
Dexcom CEO goes on leave while Insulet taps new CFO
Sep 17, 2025 12:15pm
Scholar Rock rocks the boat with new execs—Chutes & Ladders
May 2, 2025 8:30am
Insulet taps former J&J medtech head Ashley McEvoy to be CEO
Apr 28, 2025 11:00am
